Today I want to share with you a Substack article from Pierre Cory MD Pierre Kory is an American critical care physician who gained attention during the COVID-19 pandemic for advocating widespread off-label use of certain drugs as treatments for COVID-19, as president and co-founder of the Front LineRead
Prostate cancer…many of us know someone who is dealing with or who has successfully managed their prostate cancer. Why? This disease has become so prevalent in the past few decades that it’s now the second most common cancer in men worldwide — and it continues to be one of theRead
Colon cancer is one of the most common cancers in the United States, with more than 100,000 new cases diagnosed each year. It’s also the third leading cause of cancer-related death in men, and the fourth-leading cause in women, contributing to more than 50,000 deaths each year. While treatments haveRead
The debate over soy and its relation to breast cancer has been a long—and confusing—one. For many years, it was thought that soy might increase the risk of breast cancer, due mainly to its concentration of isoflavones, naturally occurring chemicals that mimic the effects of estrogen in the body. ResearchRead
Beans, beans, good for the…gut? They are. At least according to new research from the University of Texas MD Anderson Cancer Center. Their study, which involved incorporating navy beans into the diets of colorectal cancer (CRC) survivors found that these common legumes have the potential to positively impact both gutRead
Chemotherapy-induced peripheral neuropathy (CIPN) is a fairly common side effect of cancer treatment, affecting some 30-40 percent of patients. It occurs when the drugs used to treat cancer cause damage to nerves away from the brain and spinal cord, causing symptoms such as tingling, pain, burning, numbness, and loss ofRead
Acute myeloid leukemia (AML), the most common form of blood and bone marrow cancer among adults, is known for its rapid progression and resistance to treatment. “Treating acute myeloid leukemia is challenging because of these persistent, leukemia-initiating stem cells, which are typically not targeted by most existing therapies,” says SandeepRead
Prostate cancer is the second most common cause of cancer-related death in men. While there have been several diagnostic and treatment advancements in recent years, the options for men with biochemically relapsed prostate cancer (BRPC), an aggressive form of the disease, have historically been limited — until now. According toRead
Medical research is usually initiated by doctors and scientists working in hospitals and laboratories. But sometimes, patient input can spur new discoveries. That was the case with a study published in the journal Cancer Discovery, which has uncovered what appears to be a new method for early breast cancer diagnosis.Read
A study published in the journal Nature shows that curcumin, an active compound in the curry spice turmeric, can suppress the metastasis of colorectal cancer cells.
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
